Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-044630

SVP and General Counsel sold 4,167 shares at an average $41.42 ($172,614)

  • SVP and General Counsel acquired 4,167 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Taylor Stacy L · SVP and General Counsel

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-30 Exercise or conversion : show line 1 in the form +1,042 $7.80 $8,128 16,078 D
2021-06-30 Exercise or conversion : show line 2 in the form +1,771 $6.55 $11,600 17,849 D
2021-06-30 Exercise or conversion : show line 3 in the form +1,354 $31.71 $42,935 19,203 D
2021-06-30 Sale : show line 4 in the form −3,772 $41.35 $155,972 15,431 D
2021-06-30 Sale : show line 5 in the form −395 $42.13 $16,641 15,036 D
Open-market sales · 4,167 sh · avg $41.42 · $172,614

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-06-30 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −1,042 22,917 D
2021-06-30 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −1,771 15,938 D
2021-06-30 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −1,354 43,334 D
Loading xslF345X03/doc4.xml…